Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.8567
-0.0444 (-4.93%)
At close: Oct 2, 2026, 4:00 PM EDT
0.8907
+0.0340 (3.97%)
After-hours: Oct 2, 2026, 7:59 PM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
154955200199633309
Market Cap Growth
-73.24%378.75%0.34%-68.61%105.02%-
Enterprise Value
-167457137516292
Last Close Price
0.865.371.451.565.033.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--234.71---
PB Ratio
0.934.851.591.343.492.21
P/TBV Ratio
0.934.851.591.343.492.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--83.51---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.050.050.010.020.03
Net Debt / Equity Ratio
-1.02-1.01-0.96-1.01-1.01-1.00
Net Debt / EBITDA Ratio
2.102.742.143.044.494.58
Net Debt / FCF Ratio
3.024.052.683.715.356.52
Asset Turnover
--0.01---
Quick Ratio
11.1514.9614.2819.5411.5413.59
Current Ratio
11.2215.0214.9619.7312.0513.84
Return on Equity (ROE)
-56.66%-41.29%-36.07%-25.74%-24.39%-91.30%
Return on Assets (ROA)
-33.03%-25.29%-23.81%-17.66%-14.73%-19.00%
Return on Capital Employed (ROCE)
-46.60%-35.40%-43.10%-33.80%-22.70%-21.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-47.61%-6.96%-24.75%-21.37%-6.19%-26.60%
FCF Yield
-36.54%-5.15%-22.50%-20.44%-5.42%-6.98%
Buyback Yield / Dilution
-31.82%-14.78%-8.15%-20.76%-67.31%-104.28%
SEC Filings: 10-K · 10-Q